Trial NCT01994824

View at ClinicalTrials.gov 
Org. Study IDs: PreemptiveATG

Last trial update was posted on 2023-11-30

MeSH Interventions

Antilymphocyte Serum Thymoglobulin

MeSH Conditions

Graft vs Host Disease

Other Conditions

Graft-vs-host Disease

Stopping Reasons

The trend was observed toward higher mortality among the patients receiving the intervention Thymoglobulin on day 8 after hematopoietic cell transplantation.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID